Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Lloyd Segal | M | 60 |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 ans |
| John M. Langstaff | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 ans |
| Dirk Alkema | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 17 ans |
| Michael Churchill-smith | M | - |
McGill University
| 37 ans |
| Nicolas Matziorinis | M | - |
McGill University
| 36 ans |
| Ian Mumford | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 ans |
| Johan Vandersande | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 ans |
| Keith Tucker | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 7 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Nicola Urbani | M | - |
McGill University
| 11 ans |
| Steve Satov | M | - |
McGill University
| 6 ans |
| Gillian Holcroft | F | - |
McGill University
| 4 ans |
| Lance Eckel | M | - |
McGill University
| 4 ans |
| Adam Shine | M | - |
McGill University
| 7 ans |
| Laurence Nicole Mengin de Loyer | F | 56 |
McGill University
| 4 ans |
| Nicholas Green | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 9 ans |
| Thomas Wellner | M | 59 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 3 ans |
| Luigi Fraquelli | M | - |
McGill University
| 6 ans |
| Ravila Gupta | F | 60 |
McGill University
| 6 ans |
| Warren Clamen | M | 58 |
McGill University
| 4 ans |
| Nicole Crawford | F | - |
McGill University
| 4 ans |
| Dean Larson | M | - |
McGill University
| 4 ans |
| Carole Cohen-Perez | F | - |
McGill University
| 4 ans |
| Christian Drapeau | M | - |
McGill University
| 4 ans |
| Riccardo Gregory Magini | M | - |
McGill University
| 4 ans |
| Michael Stewart Shunock | M | - |
McGill University
| 4 ans |
| David Neuburger | M | 65 |
McGill University
| 4 ans |
| Yoke Keong Yong | M | 64 |
McGill University
| 2 ans |
| Clifford Minn Rhee | M | 56 |
McGill University
| 4 ans |
| Rima Qureshi | F | 59 |
McGill University
| 4 ans |
| Peter G. Wilson | M | 61 |
McGill University
| 4 ans |
| Fred Harding | M | - |
McGill University
| 4 ans |
| Colinda Parent | F | - |
McGill University
| 4 ans |
| Trevor Boyd | M | - |
McGill University
| 1 ans |
| Kendrick C. Fong | M | - |
McGill University
| 4 ans |
| Adam Berger | M | - |
McGill University
| 4 ans |
| Hugh Macdonnell | M | - |
McGill University
| 4 ans |
| James Reid | M | - |
McGill University
| 4 ans |
| Hiu Fung Pang | M | 54 |
McGill University
| 4 ans |
| Ji Ye Mao | M | 61 |
McGill University
| 2 ans |
| Frank Tomaselli | M | 60 |
McGill University
| 4 ans |
| Ian Burney | M | - |
McGill University
| 4 ans |
| Alexander Rothwell | M | - |
McGill University
| 4 ans |
| Anne T. Kuriakose | M | - |
McGill University
| 4 ans |
| Natalie Piccinin | F | 59 |
McGill University
| 3 ans |
| Rodney Findley | M | - |
McGill University
| 4 ans |
| Guy Lafond | M | - |
McGill University
| 4 ans |
| Sheryl L. Newman | F | - |
McGill University
| 4 ans |
| Manon Plante | F | - |
McGill University
| 4 ans |
| Thomas Folinsbee | M | 57 |
McGill University
| 4 ans |
| Marc Olivier | M | - |
McGill University
| 3 ans |
| Danny Grant | M | - |
McGill University
| 11 ans |
| Ann Martin | F | - |
McGill University
| 2 ans |
| Hidekazu Horikoshi | M | 62 |
McGill University
| 2 ans |
| Daniel Dorey | M | 64 |
McGill University
| 2 ans |
| Guo Hua Chen | M | 60 |
McGill University
| 1 ans |
| Nadine Block | F | - |
McGill University
| 2 ans |
| Chris Kwan | M | - |
McGill University
| 4 ans |
| Scott Jones | M | 68 |
McGill University
| 4 ans |
| George Saroglou | M | 59 |
McGill University
| 4 ans |
| Colin Osborne | M | 59 |
McGill University
| 4 ans |
| John Saabas | M | - |
McGill University
| 3 ans |
| Brent Lokash | M | 56 |
McGill University
| 4 ans |
| Elias Georges | M | - |
McGill University
| 3 ans |
| Bertrand M. Millot | M | - |
McGill University
| 2 ans |
| Nelson Gentiletti | M | 62 |
McGill University
| 3 ans |
| Laurent Hallé | M | - |
McGill University
| 3 ans |
| Dino Rambidis | M | - |
McGill University
| 1 ans |
| Bernard Poznanski | M | 66 |
McGill University
| 3 ans |
| Tim N. Foote | M | - |
McGill University
| 4 ans |
| Lorne Abony | M | 55 |
McGill University
| 4 ans |
| James Wallace MacGregor | M | - |
McGill University
| 4 ans |
| Sébastien Rhéaume | M | - |
McGill University
| 4 ans |
| Mitchell Garber | M | 59 |
McGill University
| 4 ans |
| Anthony Gerstein | M | 55 |
McGill University
| 4 ans |
| Tim Hylton | M | 56 |
McGill University
| 4 ans |
| Christine Jai Poole | F | - |
McGill University
| 3 ans |
| Elliot Cooperstone | M | 62 |
McGill University
| 3 ans |
| Spiro Plagakis | M | - |
McGill University
| 4 ans |
| H. Norton | M | 63 |
McGill University
| 3 ans |
| Kenneth S. Adessky | M | 60 |
McGill University
| 3 ans |
| Peter Winkley | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 1 ans |
| Enrique Julian Joseph Bernard Lõpez de Mesa | M | 60 |
McGill University
| 4 ans |
| Bradley Semmelhaack | M | - |
McGill University
| 4 ans |
| Courtney Manning Oldrin | F | - |
McGill University
| 4 ans |
| Simon Lussier | M | - |
McGill University
| 4 ans |
| Paolo Boni | M | - |
McGill University
| 4 ans |
| Anne Martin-Vachon | F | 62 |
McGill University
| 2 ans |
| Denis Fragias | M | - |
McGill University
| 4 ans |
| Azam Dawood | M | - |
McGill University
| 4 ans |
| Tom Heintzman | M | - |
McGill University
| 3 ans |
| James W. G. Turner | M | 59 |
McGill University
| 4 ans |
| Peter Cashin | M | 68 |
McGill University
| 1 ans |
| Christopher Reynolds | M | 60 |
McGill University
| 4 ans |
| Trent Mell | M | 54 |
McGill University
| 4 ans |
| Marc Lemieux | M | - |
McGill University
| 3 ans |
| Silvio Marsili | M | - |
McGill University
| 2 ans |
| Craig Leon | M | 56 |
McGill University
| 4 ans |
| Patrick Gagnon | M | 61 |
McGill University
| 4 ans |
| Sharon Langshur | M | - |
McGill University
| 4 ans |
| Prav Pillay | M | - |
McGill University
| 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Canada | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David N. Bell
- Réseau Personnel
